254 related articles for article (PubMed ID: 21934585)
1. A mobile compression device compared with low-molecular-weight heparin for prevention of venous thromboembolism in total hip arthroplasty.
Hardwick ME; Pulido PA; Colwell CW
Orthop Nurs; 2011; 30(5):312-6. PubMed ID: 21934585
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE
J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309
[TBL] [Abstract][Full Text] [Related]
3. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
4. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
5. A mobile compression device for thrombosis prevention in hip and knee arthroplasty.
Colwell CW; Froimson MI; Anseth SD; Giori NJ; Hamilton WG; Barrack RL; Buehler KC; Mont MA; Padgett DE; Pulido PA; Barnes CL
J Bone Joint Surg Am; 2014 Feb; 96(3):177-83. PubMed ID: 24500578
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients.
Patel AR; Crist MK; Nemitz J; Mayerson JL
J Surg Oncol; 2010 Sep; 102(3):276-81. PubMed ID: 20740587
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
Tian H; Song F; Zhang K; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
[TBL] [Abstract][Full Text] [Related]
8. Portable compression device and low-molecular-weight heparin compared with low-molecular-weight heparin for thromboprophylaxis after total joint arthroplasty.
Edwards JZ; Pulido PA; Ezzet KA; Copp SN; Walker RH; Colwell CW
J Arthroplasty; 2008 Dec; 23(8):1122-7. PubMed ID: 18534421
[TBL] [Abstract][Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
11. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
[TBL] [Abstract][Full Text] [Related]
12. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
13. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
14. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
O'Carroll CB; Capampangan DJ; Aguilar MI; Bravo TP; Hoffman-Snyder CR; Wingerchuk DM; Wellik KE; Demaerschalk BM
Neurologist; 2011 Jul; 17(4):232-5. PubMed ID: 21712672
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression Devices.
Chibbaro S; Cebula H; Todeschi J; Fricia M; Vigouroux D; Abid H; Kourbanhoussen H; Pop R; Nannavecchia B; Gubian A; Prisco L; Ligarotti GKI; Proust F; Ganau M
World Neurosurg; 2018 Jan; 109():e510-e516. PubMed ID: 29033376
[TBL] [Abstract][Full Text] [Related]
16. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
[TBL] [Abstract][Full Text] [Related]
17. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
Anderson DR; Dunbar MJ; Bohm ER; Belzile E; Kahn SR; Zukor D; Fisher W; Gofton W; Gross P; Pelet S; Crowther M; MacDonald S; Kim P; Pleasance S; Davis N; Andreou P; Wells P; Kovacs M; Rodger MA; Ramsay T; Carrier M; Vendittoli PA
Ann Intern Med; 2013 Jun; 158(11):800-6. PubMed ID: 23732713
[TBL] [Abstract][Full Text] [Related]
18. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
19. Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial.
Snyder MA; Sympson AN; Scheuerman CM; Gregg JL; Hussain LR
J Arthroplasty; 2017 May; 32(5):1478-1482. PubMed ID: 28159420
[TBL] [Abstract][Full Text] [Related]
20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]